Intelligent equipment is being more and more widely used in pharmaceutical production!

【Pharmaceutical Network Industry News】In recent years, due to the promotion of medical reform policies such as consistency evaluation and centralized procurement, the pharmaceutical industry is accelerating transformation and upgrading and developing
in the direction of high quality.
Intelligent equipment is being more and more widely used in pharmaceutical production! (Image source: Pharmaceutical Network) It is understood that in the past, in terms of production, only a few pharmaceutical companies in China reached a certain degree of process automation, and the vast majority of enterprises stayed in the single automation stage
of equipment control.
For example, in the production of preparations, most of the production equipment and processes are disconnected and isolated; A considerable part of the transfer of raw and auxiliary materials and intermediate products in the production process is still mainly manual; In addition, a considerable number of equipment does not have a complete data output function of important quality parameters and process condition parameters, let alone provide input conditions
for unified coordination and optimal control of external systems.
With the continuous improvement and application of digital technologies such as artificial intelligence, big data, and AI, more and more pharmaceutical companies in the pharmaceutical industry have begun to accelerate the development of new drugs and optimize production by using intelligent equipment and production
lines.
For example, Northeast Pharmaceutical, as an important drug production and export base in China, has been using digital empowerment as a breakthrough to improve product quality and market competitiveness in recent years, fully releasing the dividends
of digital transformation.
It is reported that earlier, Northeast Pharmaceutical was vigorously promoting the overall construction of
the pharmaceutical intelligent manufacturing industrial park.
At present, the equipment working conditions, material status, plan execution, etc.
of the production lines of each branch of the company's API factory have been tracked and traced in real time, and the control process of the production workshop has also been visualized
.
At the same time, multi-dimensional and penetrating management of safety and environmental protection work is carried out, so that the traceability of all-factor quality with drug batches as the core becomes a reality
.
In addition, the company has also built a safety management self-feedback system platform around production, realizing real-time monitoring
of temperature, pressure, liquid level and operating status of production equipment and material storage tanks.
At present, the company has built a big data analysis platform to support data integration, and established an 'enterprise data warehouse' to effectively link
data in production, sales, finance, human resources and other sectors.
On October 26th, the groundbreaking ceremony of Liaoning Dianguan Technology Co.
, Ltd.
intelligent equipment manufacturing base project was held
in the high-tech zone.
It is understood that the total investment of the intelligent automation equipment production base construction project is 219 million yuan, and it is committed to building a future-oriented high-flexibility intelligent packaging line production base
in accordance with the standardized design of Industry 4.
0 intelligent manufacturing.
On October 25, Beikang submitted the listing application documents of the Beijing Stock Exchange to the China Securities Regulatory Commission, intending to raise about 500 million yuan in IPO for the construction of Chengdu intelligent manufacturing production base
.
Earlier, Hualan Biotech also said on the investor interactive platform that Hualan Biomedical R&D and intelligent production base has started construction
.
The production workshop of the project will adopt advanced design concepts, equipped with high-tech instruments and equipment, and realize the whole process of production process "automation, informatization and intelligence"
.
.
.
.
.
.
.
From the current point of view, pharmaceutical companies are helping pharmaceutical enterprises realize vertical penetration and integrated management
from the process control point to the equipment system to the overall automation and information control layer of the workshop from the dimension of the whole life cycle of the product, based on intelligent equipment, automation, information software, big data, and cloud technology, and guided by the quality needs of pharmaceutical processes.
The industry believes that in this context, pharmaceutical "manufacturing" will continue to accelerate to "intelligent manufacturing", the production process of pharmaceutical enterprises will continue to be optimized, production efficiency will be further improved, and product quality and production capacity will also be greatly improved
.
It is worth noting that at present, with the continuous acceleration of intelligent upgrading of the pharmaceutical industry, in fact, pharmaceutical equipment companies are also actively developing intelligent pharmaceutical equipment and building intelligent factories, and vigorously developing
in the direction of "unmanned, less manpower, and intelligence".
It is understood that the innovation and development of enterprises such as Mudong Fulong, Chutian Technology and Canaan Technology in product intelligence has been steadily progressing, and the results are also emerging
.
For example, Chutian Technology Xilin bottle high-speed intelligent packaging production line has been widely used in large-scale production, and successfully solved industry problems such as the influence of temperature on drugs, and also broke through the industry bottleneck in the packaging process such as quality control, fault guidance and automatic packaging materials, reaching the international level
.
In addition, in August this year, Canaan Technology's solid dosage intelligent manufacturing system was selected into the list
of Zhejiang Engineering Research Center.
In December 2021, the "14th Five-Year Plan" for Intelligent Manufacturing Development issued by eight departments proposed that by 2025, 70% of manufacturing enterprises above designated size will basically achieve digital networking
.
The industry expects that the intelligent trend of the pharmaceutical equipment industry will become more and more obvious, and intelligent equipment will be more widely used
in pharmaceutical production.
Disclaimer: Under no circumstances does the information or opinions expressed herein constitute investment advice
to anyone.